collaborate
collaborators
funding partners
affiliations
areas of collaboration
antigen discovery | development
adjuvant discovery | development |
delivery
product development
drug discovery
Chembio's long and successful history with IDRI is testimony to their superior antigen discovery skills and global network of expertise. This, combined with our mutual commitment to global health and a complementary approach in our research and development collaborations together, has produced outstanding results.
Lawrence Siebert, CEO, Chembio Diagnostic Systems, Inc.
| |
Antigen Discovery | Development
Antigens are substances that promote an immune response when introduced into the body. In small amounts, they are useful in the production of vaccines, as well as in developing methods for detecting disease pathogens in patients or in the blood supply. Currently, there are many global diseases for which there are no vaccines and for which improved diagnostic products are needed. Our Antigen Development team has experience producing antigens, typically proteins or complex sugars called "polysaccharides," that can be used to diagnose and vaccinate against these diseases.
Our Antigen Development team uses many techniques to identify potential vaccine antigens. We currently possess proprietary antigens that are being used in a number of vaccine development programs.
We are interested in collaborating with others with novel antigens, as well as partnering with entities with complementary technology that can be used together with our antigens for additional vaccine and diagnostic programs.
|
